SUPERNUS PHARMACEUTICALS INC's ticker is SUPN and the CUSIP is 868459108. A total of 240 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is 0.33 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $1,592,523 | +5.4% | 44,646 | +0.0% | 0.26% | +12.7% |
| Q3 2022 | $1,511,000 | -20.8% | 44,634 | -32.3% | 0.23% | +36.3% |
| Q2 2022 | $1,907,000 | +271.0% | 65,943 | +131.0% | 0.17% | +309.8% |
| Q1 2020 | $514,000 | +44.0% | 28,550 | +89.9% | 0.04% | +86.4% |
| Q4 2019 | $357,000 | -82.0% | 15,038 | -84.6% | 0.02% | -86.0% |
| Q2 2016 | $1,988,000 | +33.6% | 97,600 | 0.0% | 0.16% | +68.8% |
| Q1 2016 | $1,488,000 | -2.6% | 97,600 | -14.2% | 0.09% | -55.5% |
| Q4 2015 | $1,528,000 | +11.6% | 113,700 | +16.5% | 0.21% | +574.2% |
| Q3 2015 | $1,369,000 | -17.9% | 97,600 | -0.6% | 0.03% | -29.5% |
| Q2 2015 | $1,667,000 | +189.9% | 98,200 | +106.6% | 0.04% | +214.3% |
| Q1 2015 | $575,000 | +197.9% | 47,541 | +120.7% | 0.01% | +180.0% |
| Q1 2014 | $193,000 | – | 21,539 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 426,500 | $11,754,340 | 3.96% |
| ASHFORD CAPITAL MANAGEMENT INC | 916,747 | $25,274,715 | 3.72% |
| ARMISTICE CAPITAL, LLC | 5,092,000 | $140,386,440 | 2.15% |
| S&T BANK/PA | 215,578 | $5,943 | 1.15% |
| Aristotle Capital Boston, LLC | 1,187,981 | $32,752,634 | 1.06% |
| RICE HALL JAMES & ASSOCIATES, LLC | 544,468 | $15,010,983 | 0.95% |
| Tributary Capital Management, LLC | 352,429 | $9,716,468 | 0.92% |
| Bridge City Capital, LLC | 65,297 | $1,800,238 | 0.91% |
| Integral Health Asset Management, LLC | 220,000 | $6,065,400 | 0.84% |
| Retirement Planning Co of New England, Inc. | 51,608 | $1,422,833 | 0.79% |